AIXC Share Price Performance
US$2.56
-1.72 (-40.19%)
Price US$2.56
Share Pricen/a
Is AIxCrypto Holdings (NASDAQ:AIXC) Weighed On By Its Debt Load?
Dec 30
AIxCrypto Holdings, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
AIXC Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AIxCrypto Holdings, Inc. Key Details
About AIXC
- Founded
- 1996
- Employees
- n/a
- CEO
- WebsiteView website
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company’s lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
